117 related articles for article (PubMed ID: 26351494)
1. Are Osteopontin and Ki67 Expressions Different in Various Histologic Grades of Meningioma? An Iranian Experience.
Hashemi F; Babaheidarian P; Dabiran S
Iran J Pathol; 2015; 10(4):253-7. PubMed ID: 26351494
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin predicts the behaviour of atypical meningioma.
Lin CK; Tsai WC; Lin YC; Hueng DY
Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas.
Arikök AT; Onder E; Seçkin H; Kaçar A; Fesli R; Oğuz AS; Alper M
Brain Tumor Pathol; 2014 Apr; 31(2):94-100. PubMed ID: 23793814
[TBL] [Abstract][Full Text] [Related]
4. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin and Ki-67 expression in World Health Organization graded canine meningioma.
Janssen J; Oevermann A; Walter I; Tichy A; Kummer S; Gradner G
J Comp Pathol; 2023 Feb; 201():41-48. PubMed ID: 36706466
[TBL] [Abstract][Full Text] [Related]
6. The role of osteopontin and its receptor in meningioma development and progression.
Li HZ; Gong HD; Wang C; Li JK
J Biol Regul Homeost Agents; 2018; 32(1):69-74. PubMed ID: 29504367
[TBL] [Abstract][Full Text] [Related]
7. Meningiomas: correlation of Ki67 with histological grade.
Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki67: comparison of the proliferation index between meningiomas with and without infiltration of glial tissue.
Zehani A; Chelly I; Haouet S; Kchir N
Tunis Med; 2017 Jul; 95(7):466-470. PubMed ID: 29694649
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis.
Harb OA; Elsayed WS; Ismail EI; Toam MM; Ammar MG
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2299-2308. PubMed ID: 28843270
[TBL] [Abstract][Full Text] [Related]
10. Periostin: a novel prognostic predictor for meningiomas.
Liu Y; Shi J; Chen M; Cao YF; Liu YW; Pan J; Qi ST
J Neurooncol; 2015 Feb; 121(3):505-12. PubMed ID: 25519301
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of P57, P53 and Ki67 Expression in Meningiomas.
Küçükosmanoğlu İ; Karanis MİE; Ünlü Y; Çöven İ
J Korean Neurosurg Soc; 2022 Jul; 65(4):499-506. PubMed ID: 35418006
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Impact of FOXM1 and MMP-9 Immunohistochemical Expression in Different Grades of Intracranial Meningioma.
Ibrahim HM; Abdelrahman AE; Elwan A; Gharieb SA; Refaat M; Elmesallamy W; Salem AA
Appl Immunohistochem Mol Morphol; 2024 Jun; ():. PubMed ID: 38863278
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
15. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
[TBL] [Abstract][Full Text] [Related]
17. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
[TBL] [Abstract][Full Text] [Related]
18. Angiomatous meningioma: a clinicopathologic study of 38 cases.
Hasselblatt M; Nolte KW; Paulus W
Am J Surg Pathol; 2004 Mar; 28(3):390-3. PubMed ID: 15104303
[TBL] [Abstract][Full Text] [Related]
19. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
20. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]